| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/07/2023 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 10/25/2023 | 108.53% | Roth MKM | → $44 | Upgrades | Neutral → Buy |
| 10/20/2023 | 103.79% | Exane BNP Paribas | → $43 | Initiates Coverage On | → Neutral |
| 10/12/2023 | 160.66% | Oppenheimer | $67 → $55 | Maintains | Outperform |
| 10/06/2023 | 179.62% | Piper Sandler | $64 → $59 | Maintains | Overweight |
| 10/03/2023 | 160.66% | Raymond James | $65 → $55 | Maintains | Outperform |
| 08/01/2023 | 245.97% | Craig-Hallum | $68 → $73 | Maintains | Buy |
| 08/01/2023 | 193.84% | Baird | $54 → $62 | Maintains | Outperform |
| 08/01/2023 | 217.54% | Oppenheimer | $65 → $67 | Maintains | Outperform |
| 06/30/2023 | 193.84% | B. Riley Securities | $63 → $62 | Maintains | Buy |
| 05/18/2023 | 151.18% | B of A Securities | $59 → $53 | Maintains | Buy |
| 05/16/2023 | 279.15% | EF Hutton | → $80 | Reiterates | Buy → Buy |
| 05/02/2023 | 279.15% | EF Hutton | → $80 | Reiterates | → Buy |
| 05/02/2023 | 208.06% | Oppenheimer | $64 → $65 | Maintains | Outperform |
| 05/02/2023 | 184.36% | UBS | → $60 | Initiates Coverage On | → Buy |
| 04/25/2023 | 198.58% | B. Riley Securities | $72 → $63 | Maintains | Buy |
| 04/05/2023 | 208.06% | Raymond James | $70 → $65 | Maintains | Outperform |
| 03/10/2023 | 203.32% | Piper Sandler | $57 → $64 | Upgrades | Neutral → Overweight |
| 03/01/2023 | 108.53% | Roth Capital | → $44 | Upgrades | Sell → Neutral |
| 02/28/2023 | 222.27% | Craig-Hallum | $82 → $68 | Maintains | Buy |
| 02/28/2023 | 203.32% | Oppenheimer | $76 → $64 | Maintains | Outperform |
| 02/28/2023 | 155.92% | Baird | $70 → $54 | Maintains | Outperform |
| 02/28/2023 | 279.15% | EF Hutton | $86 → $80 | Maintains | Buy |
| 11/02/2022 | 283.89% | Canaccord Genuity | $79 → $81 | Maintains | Buy |
| 10/25/2022 | 245.97% | B. Riley Securities | $70 → $73 | Maintains | Buy |
| 10/13/2022 | 231.75% | Raymond James | $65 → $70 | Maintains | Market Outperform |
| 09/26/2022 | 245.97% | B of A Securities | $74 → $73 | Upgrades | Neutral → Buy |
| 08/02/2022 | 288.63% | Stifel | $91 → $82 | Maintains | Buy |
| 08/02/2022 | 288.63% | Craig-Hallum | $95 → $82 | Maintains | Buy |
| 07/26/2022 | 231.75% | B. Riley Securities | $92 → $70 | Maintains | Buy |
| 07/19/2022 | 170.14% | Piper Sandler | $62 → $57 | Maintains | Neutral |
| 07/12/2022 | 208.06% | Raymond James | $85 → $65 | Maintains | Outperform |
| 04/05/2022 | 302.84% | Raymond James | $70 → $85 | Maintains | Outperform |
| 03/24/2022 | 283.89% | B of A Securities | $85 → $81 | Downgrades | Buy → Neutral |
| 03/14/2022 | 203.32% | Piper Sandler | $80 → $64 | Maintains | Neutral |
| 03/09/2022 | 302.84% | B of A Securities | $61 → $85 | Maintains | Buy |
| 03/01/2022 | 331.28% | Stifel | $92 → $91 | Maintains | Buy |
| 03/01/2022 | 231.75% | Raymond James | $65 → $70 | Maintains | Outperform |
| 02/02/2022 | 189.1% | B of A Securities | $88 → $61 | Upgrades | Neutral → Buy |
| 01/20/2022 | 208.06% | Raymond James | → $65 | Upgrades | Market Perform → Outperform |
| 11/04/2021 | 354.98% | Piper Sandler | $80 → $96 | Downgrades | Overweight → Neutral |
| 11/02/2021 | 373.93% | B. Riley Securities | $75 → $100 | Maintains | Buy |
| 08/04/2021 | 245.97% | Canaccord Genuity | $82 → $73 | Maintains | Buy |
| 07/23/2021 | 231.75% | B of A Securities | $65 → $70 | Downgrades | Buy → Neutral |
| 07/19/2021 | 264.93% | Piper Sandler | → $77 | Initiates Coverage On | → Overweight |
| 06/10/2021 | 208.06% | B of A Securities | $54 → $65 | Maintains | Buy |
| 04/08/2021 | 174.88% | Stifel | → $58 | Initiates Coverage On | → Buy |
| 04/07/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 03/25/2021 | 141.71% | Baird | → $51 | Initiates Coverage On | → Outperform |
| 03/03/2021 | 288.63% | Canaccord Genuity | $52 → $82 | Maintains | Buy |
| 01/29/2021 | 198.58% | Guggenheim | → $63 | Initiates Coverage On | → Buy |
| 11/03/2020 | 103.79% | Oppenheimer | $33 → $43 | Maintains | Outperform |
| 10/15/2020 | 136.97% | Canaccord Genuity | $36 → $50 | Maintains | Buy |
| 07/22/2020 | — | Raymond James | Downgrades | Strong Buy → Market Perform | |
| 07/09/2020 | 46.92% | Raymond James | $25 → $31 | Maintains | Strong Buy |
| 06/09/2020 | 56.4% | Craig-Hallum | → $33 | Initiates Coverage On | → Buy |
| 05/05/2020 | 13.74% | Oppenheimer | $26 → $24 | Maintains | Outperform |
| 03/04/2020 | 42.18% | B. Riley Securities | $19 → $30 | Maintains | Buy |
| 03/03/2020 | 23.22% | Oppenheimer | $20 → $26 | Maintains | Outperform |
| 11/22/2019 | -5.21% | Raymond James | → $20 | Initiates Coverage On | → Strong Buy |
| 03/04/2019 | — | Roth Capital | Upgrades | Neutral → Buy | |
| 12/19/2018 | -17.06% | B. Riley Securities | → $17.5 | Initiates Coverage On | → Buy |
What is the target price for Ameresco (AMRC)?
The latest price target for Ameresco (NYSE: AMRC) was reported by Oppenheimer on November 7, 2023. The analyst firm set a price target for $0.00 expecting AMRC to fall to within 12 months (a possible -100.00% downside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ameresco (AMRC)?
The latest analyst rating for Ameresco (NYSE: AMRC) was provided by Oppenheimer, and Ameresco downgraded their perform rating.
When is the next analyst rating going to be posted or updated for Ameresco (AMRC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ameresco, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ameresco was filed on November 7, 2023 so you should expect the next rating to be made available sometime around November 7, 2024.
Is the Analyst Rating Ameresco (AMRC) correct?
While ratings are subjective and will change, the latest Ameresco (AMRC) rating was a downgraded with a price target of $0.00 to $0.00. The current price Ameresco (AMRC) is trading at is $21.10, which is out of the analyst's predicted range.